EUVIMEDEUVIMED entdecken
Crossref

CERT1: A Novel Exploratory Nogo-A Binding Protein in Non-Small Cell Lung Cancer

Weihuan Li, Yanlan Sun, Xiaoyun Chen, Yonggui Yuan, Lei Cai, Lin He

Journal of Bio-X Research · 01.01.2026 · 9

DOI: 10.34133/jbioxresearch.0081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bio-X Research, online erschienen am 28.05.2026. Verfasst von Weihuan Li und 5 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Shanghai Municipality.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nogo-A is well known as an inhibitor of neurite outgrowth. Accumulating evidence suggests that it may also participate in the pathogenesis of non-small cell lung cancer (NSCLC), an aggressive malignancy with a 5-year survival rate of only 16.6%. However, the role of Nogo-A in NSCLC remains poorly understood, partly due to the potential cross-reactivity of antibodies targeting different Nogo isoforms, which may lead to ambiguous results. Here, we employed bioinformatics analyses to identify candidate binding proteins of Nogo-A, followed by coimmunoprecipitation (Co-IP) for experimental validation. A 2-step protein–protein docking procedure combined with molecular dynamics (MD) simulations was subsequently performed to explore the possible binding mechanisms between Nogo-A and CERT1. In addition, a protein–protein interaction network was constructed to explore the possible functional role of Nogo-A in NSCLC. The results revealed that Nogo-A expression was elevated in NSCLC tissues compared with normal tissues. CERT1, SNX15, and SYT16 were identified as candidate Nogo-A-binding proteins, among which CERT1 was experimentally confirmed to bind with Nogo-A in H1299 NSCLC cells overexpressing Nogo-A. MD simulations further suggested that Nogo-A might bind to CERT1 via its reticulon homology domain (RHD), with the interaction involving both the PH and START domains of CERT1. Network enrichment analysis indicated that Nogo-A might be involved in apoptotic processes through the modulation of CERT1-mediated ceramide binding and transport. Taken together, our findings identify CERT1 as a novel putative interacting partner of Nogo-A in NSCLC. The predicted binding interface and its potential functional association with apoptosis provide a basis for future mechanistic studies.

Förderung

  • Natural Science Foundation of Shanghai Municipality

Zitieren

APA

Li, W., Sun, Y., Chen, X., Yuan, Y., Cai, L., & He, L. (2026). CERT1: A Novel Exploratory Nogo-A Binding Protein in Non-Small Cell Lung Cancer. Journal of Bio-X Research, 9. https://doi.org/10.34133/jbioxresearch.0081

Vancouver

Li W, Sun Y, Chen X, Yuan Y, Cai L, He L. CERT1: A Novel Exploratory Nogo-A Binding Protein in Non-Small Cell Lung Cancer. Journal of Bio-X Research. 2026;9. doi:10.34133/jbioxresearch.0081

BibTeX
@article{Li2026,
  author = {Li, Weihuan and Sun, Yanlan and Chen, Xiaoyun and Yuan, Yonggui and Cai, Lei and He, Lin},
  title = {CERT1: A Novel Exploratory Nogo-A Binding Protein in Non-Small Cell Lung Cancer},
  journal = {Journal of Bio-X Research},
  year = {2026},
  volume = {9},
  doi = {10.34133/jbioxresearch.0081}
}
Kostenlos starten →